Loading...

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

BACKGROUND: Despite improvements in medical care, patients with advanced cancer still experience substantial symptom distress. There is increasing interest in the use of medicinal cannabinoids but little high-quality evidence to guide clinicians. This study aims to define the role of a 1:1 delta-9-t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Trials
Main Authors: Hardy, Janet, Haywood, Alison, Gogna, Gauri, Martin, Jennifer, Yates, Patsy, Greer, Ristan, Good, Phillip
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336664/
https://ncbi.nlm.nih.gov/pubmed/32631447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04541-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!